Monday, March 24, 2008

Lucid’s VivaScope® Reflective Confocal Microscope Approved for Sale in China

ROCHESTER, NY, USA, - March 24, 2008 – China’s State Food and Drug Administration has approved the sale of the pioneering Lucid VivaScope® reflective confocal microscope in the Peoples Republic of China, said Jay Eastman, CEO of Lucid, a Rochester, New York-based medical device and information company dedicated to providing improved care for dermatology patients.

Lucid’s VivaScope® reflective confocal microscopes (RCM) provide non-invasive, in-vivo cellular resolution images of skin. Dermatologists can use the images to form a clinical judgment for a variety of skin conditions -- without the need for surgery to excise tissue – thus improving the quality of care for their patients.

“Just as MRI and CT scans have largely eliminated the need for routine ‘exploratory surgery’, the use of Lucid’s VivaScope® confocal microscopes may one day eliminate the need for routine invasive skin biopsies,” Eastman explained.

“This milestone announcement opens opportunities for application of confocal microscopes to evaluate and monitor treatment of skin inflammatory and pigmentation disorders with leading hospitals throughout China,” Eastman said.

“I am very pleased to see this positive outcome from a long and detailed review process that will allow us to participate in one of the fastest growing medical markets in the world,” he said. “We believe that reflectance confocal microscopes will become a standard clinical tool with its capacity to take painless, non-invasive optical biopsies of a wide range of skin lesions and disorders.”

Sales of Lucid’s VivaScope® confocal microscopes in China will be handled by ConBio (China) Co., Ltd, Eastman said.

Dr Qiushi Ren, CEO, ConBio said, “We are excited by the opportunity to introduce Lucid’s unique, leading RCM technology to Chinese doctors and building our business together.”

Founded in 1996, ConBio is a multi-specialty health care company focused on providing innovative medical devices that enable people to live life to its greatest potential. ConBio has built strategic relationships with famous manufacturers in the dermatology, plastic and ophthalmologic fields around the world, including Lucid, Cutera, RA Medical, MedArt, Lutronic, Allergan, Schwind with a goal of becoming the leading provider of the advanced medical lasers, instruments and materials in China. ConBio has successfully sold more than 1,000 units of capital equipment to customers in China and prides itself on their after-sales service.

For information, visit Lucid’s website at http://www.lucid-tech.com. Contact Lucid in China at ConBio (China) Co., Ltd., by email at qren@shanghai-conbio.com or by phone at: + 86 21 62720751. In the USA, contact Lucid by email at info@lucid-tech.com, or by phone at +1-585-239-9800.

About Lucid, Inc.
Lucid, Inc. (www.lucid-tech.com), based in Rochester, New York (USA) is a medical device and information company with offices in North America, Europe, and Australia. Lucid is dedicated to providing improved care for dermatology patients by coupling its noninvasive VivaScope® cellular imaging technology with its innovative VivaNet® medical information system to allow secure, HIPAA compliant, near real-time collaboration between dermatologists and other medical specialists. The VivaNet® system provides rapid online medical image transfer, storage, and retrieval thus enabling these critical collaborative consultations. The technologies delivered by Lucid provide images that physicians use in forming critical clinical judgments in cases of dermatologic disease, while ensuring patient comfort and piece of mind.

VivaNet® and VivaScope® are registered trademarks of Lucid, Inc.


# # #

Labels: , , , , , , , , , , , ,

Thursday, August 02, 2007

Invensys wins automation order from major Chinese contractor for mega power plant project in India

-- 3,600-megawatt generating station one of the largest power plants under construction in India --

FOXBORO, MASSACHUSETTS, USA – June 21, 2007 – Invensys Process Systems (http://ips.invensys.com/) has been selected by Shandong No. 3 Electric Power Construction Corporation (SEPCO III) of China to implement Foxboro (http://www.foxboro.com/) I/A Series distributed control systems (DCS) for a 3,600-megawatt generating station being built in Jharsuguda district, Orissa state, India. The plant is one of the largest power plants under construction in India, and represents a new generation of mega-sized generating plants being built to help meet India’s bourgeoning power demand.

Extensive Invensys experience in the power industry (including a large number of projects in China) and expertise in large-scale projects were important factors in the SEPCO III contract award to Invensys.

The DCS contract will encompass an advanced I/A Series automation infrastructure integrating more than 63,000 I/O points. The systems will be used to control the new plant’s boilers, turbines and generators utilizing Invensys’ Performance Plus coordinated control system (CCS) technology, well-proven in power plants worldwide. Subsystem applications will include data acquisition system (DAS), furnace safety supervisory system (FSSS), boiler and turbine sequence control system (SCS), turbine digital electro-hydraulic (DEH) control system, feed water pump mechanical electro-hydraulic (MEH) control system, and electric control systems (ECS).

In addition to I/A Series automation hardware and software, Invensys Process Systems China will also provide a range of installation services, engineering, training, and field service.

The plant is part of the “Power for All” initiative, an aggressive Indian government plan to sustain economic growth with significant additions of power generation capacity in the next few years. The new power plant project is one of the largest projects for SEPCO III, and comprises China’s largest export machinery and equipment order to India.

About Shandong No. 3 Electric Power Construction Corporation
Shandong No. 3 Electric Power Construction Corporation (SEPCO III) is part of Shandong Electric Power Group Corporation and is a leading power EPC contractor for thermal plants, nuclear plants, gas-fired and hydropower stations. SEPCO III was one of the first Chinese power contractors to enter the global market, and has more than 160 generation units of contract experience in China and around the world, including a range of public power and captive power projects in India. Capable of providing the full range of EPC services from its experienced professional staff, SEPCO III is headquartered in Shandong, China.

About Invensys
Invensys is the world leader in industrial asset performance management, a strategy designed to help today's industrial enterprises to effectively balance the availability and utilization of their production assets to match changing business requirements. In addition to its rapidly expanding Global Solutions and Performance Management services groups, Invensys' automation businesses includes industry-leading brands such as Foxboro, Triconex, SimSci-Esscor, Wonderware, and Avantis, whose products are installed in more than 100,000 plants across the world. These range from small hybrid and batch plants to the world's largest upstream projects, refineries, gas plants, petrochemicals plants, power plants, and pulp and paper mills. For more information on Invensys' process automation businesses, please visit www.invensys.com/ps.
The Invensys Group (www.invensys.com) is headquartered in London and is listed on the London Stock Exchange, with approximately 30,000 employees working in 60 countries.

Invensys, Foxboro, I/A Series, Performance Plus, Triconex, SimSci-Esscor, and Avantis are trademarks of Invensys plc, its subsidiaries, or affiliates. All other brand and product names may be trademarks of their respective owners.
# # #

Public Relations contact: Tiziani Whitmyre Inc.

post to del.icio.us





Technorati tags: , , , , , ,

Labels: , , , , , ,